TrialPanorama/TrialPanorama-database huggingface dataset:
Study 24650336 — Predictive Biomarker (PRD): IK mRNA
Genes: IK; RED; RER
Study 12123409 — Surrogate Endpoint (SUR): Blood pressure
Study 29788791 — Predictive Biomarker (PRD): CYP2A6 mRNA
Genes: CYP2A6; CYP2A3
Study 22680238 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 22680238 — Predictive Biomarker (PRD): SELENBP1 mRNA
Genes: SELENBP1; SBP
Study 22680238 — Surrogate Endpoint (SUR): Blood pressure
Study 15818694 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 12463111 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 12463111 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8880373 — Surrogate Endpoint (SUR): Blood pressure
Study 27445317 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 27445317 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 7656458 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 31557945 — Predictive Biomarker (PRD): CHAF1A mRNA
Genes: CHAF1A; CAF; CAF1P150
Study 31557945 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 28641153 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15850317 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 30514196 — Surrogate Endpoint (SUR): Serum calcium
Study 25968593 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 25968593 — Surrogate Endpoint (SUR): Blood pressure
Study 17239474 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study 14963058 — Surrogate Endpoint (SUR): Blood pressure
Study 14963058 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 11758227 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 11758227 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 9412880 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 9412880 — Predictive Biomarker (PRD): REG3A mRNA
Genes: REG3A; HIP; PAP; PAP1
Study 9412880 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 31246234 — Surrogate Endpoint (SUR): Bone mineral density
Study 30466438 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 26894653 — Surrogate Endpoint (SUR): Serum creatinine
Study 26894653 — Surrogate Endpoint (SUR): Serum uric acid
Study 24876915 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 24876915 — Predictive Biomarker (PRD): GPX1 mRNA
Genes: GPX1
Study 24876915 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SOD2 mRNA
Genes: SOD2
Study 24876915 — Predictive Biomarker (PRD): SIRT2 mRNA
Genes: SIRT2; SIR2L; SIR2L2
Study 24876915 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study 23338259 — Predictive Biomarker (PRD): CLSTN3 mRNA
Genes: CLSTN3; CS3; KIAA0726
Study 23338259 — Predictive Biomarker (PRD): CLIC1 mRNA
Genes: CLIC1; G6; NCC27
Study 15640324 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 1369702 — Surrogate Endpoint (SUR): Blood pressure
Study 31198477 — Predictive Biomarker (PRD): KNG1 mRNA
Genes: KNG1; BDK; KNG
Study 20180356 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 16540851 — Surrogate Endpoint (SUR): Blood pressure
Study 11680666 — Surrogate Endpoint (SUR): Blood pressure
Study 11680666 — Surrogate Endpoint (SUR): Serum potassium
Study 11680666 — Surrogate Endpoint (SUR): Serum uric acid
Study 9270666 — Safety Biomarker (SAF): Succinate dehydrogenase
Genes: SDHD
Study 2454360 — Surrogate Endpoint (SUR): Blood pressure
Study 30975219 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 30430875 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study 22538054 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 19640853 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19640853 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 23372114 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10926339 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 10926339 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 4017661 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 22251615 — Surrogate Endpoint (SUR): Bone mineral density
Study 12595513 — Surrogate Endpoint (SUR): Serum creatinine
Study 1547164 — Surrogate Endpoint (SUR): Blood pressure
Study 21438849 — Predictive Biomarker (PRD): UGT2B7 mRNA
Genes: UGT2B7; UGTB2B9
Study 15298426 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 15298426 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 2857602 — Surrogate Endpoint (SUR): Blood pressure
Study 22521214 — Predictive Biomarker (PRD): PON1 mRNA
Genes: PON1; PON
Study 12830007 — Surrogate Endpoint (SUR): Serum creatinine
Study 1338584 — Safety Biomarker (SAF): Cytochrome c
Study 20978525 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 20978525 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 20158691 — Surrogate Endpoint (SUR): Bone mineral density
Study 361345 — Surrogate Endpoint (SUR): Blood pressure
Study 31257404 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 23786776 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 23786776 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 23786776 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 23786776 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 23786776 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 30524424 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 24381088 — Surrogate Endpoint (SUR): Blood pressure
Study 23106890 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 1986564 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 27498129 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 20887414 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18541827 — Surrogate Endpoint (SUR): Blood pressure
Study 6135908 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study 6135908 — Surrogate Endpoint (SUR): Plasma testosterone level
Study 30811282 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 30811282 — Predictive Biomarker (PRD): KCNH2 mRNA
Genes: KCNH2; ERG; ERG1; HERG
Study 30811282 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 19621708 — Monitoring Biomarker (MOI): HBV DNA
Study 9543364 — Surrogate Endpoint (SUR): Serum creatinine
Study 3291099 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 8153915 — Surrogate Endpoint (SUR): Forced vital capacity
Study 31479537 — Surrogate Endpoint (SUR): Blood pressure
Study 30346655 — Surrogate Endpoint (SUR): Blood pressure
Study 22314671 — Surrogate Endpoint (SUR): Forced vital capacity
Study 12665158 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 8400972 — Surrogate Endpoint (SUR): Blood pressure
Study 31654548 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 20354496 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20354496 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 20354496 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 20354496 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 20354496 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 20354496 — Safety Biomarker (SAF): IL-6 and IL-10
Study 18207289 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 6355421 — Surrogate Endpoint (SUR): Blood pressure
Study 3987782 — Surrogate Endpoint (SUR): Blood pressure
Study 26401779 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 21426747 — Surrogate Endpoint (SUR): Blood pressure
Study 31515632 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31515632 — Predictive Biomarker (PRD): HGS mRNA
Genes: HGS; HRS
Study 29772028 — Predictive Biomarker (PRD): SH2D1A mRNA
Genes: SH2D1A; DSHP; SAP
Study 16647134 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 16647134 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 10731545 — Surrogate Endpoint (SUR): Blood pressure
Study 28813214 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 28813214 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16941701 — Monitoring Biomarker (MOI): HBV DNA
Study 12953339 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 12953339 — Surrogate Endpoint (SUR): Serum creatinine
Study 12953339 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 12953339 — Surrogate Endpoint (SUR): Serum uric acid
Study 1390591 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 2861223 — Surrogate Endpoint (SUR): Blood pressure
Study 29469944 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 22316799 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 30741797 — Surrogate Endpoint (SUR): Bone mineral density
Study 23653426 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 23653426 — Safety Biomarker (SAF): BDNF
Study 21854068 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 21854068 — Surrogate Endpoint (SUR): Blood pressure
Study 21854068 — Predictive Biomarker (PRD): REN mRNA
Genes: REN
Study 19955890 — Surrogate Endpoint (SUR): Blood pressure
Study 8331198 — Surrogate Endpoint (SUR): Blood pressure
Study 3013265 — Surrogate Endpoint (SUR): Blood pressure
Study 29254067 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 19670459 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 15155118 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15155118 — Surrogate Endpoint (SUR): Blood pressure
Study 11238232 — Predictive Biomarker (PRD): CTBS mRNA
Genes: CTBS; CTB
Study 11238232 — Predictive Biomarker (PRD): CLSTN1 mRNA
Genes: CLSTN1; CS1; KIAA0911
Study 11238232 — Predictive Biomarker (PRD): CLSTN2 mRNA
Genes: CLSTN2; CS2
Study 2543304 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study 2543304 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study 21557836 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study 29720378 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 29720378 — Predictive Biomarker (PRD): PCSK5 mRNA
Genes: PCSK5; PC5; PC6
Study 27455316 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25424425 — Surrogate Endpoint (SUR): Blood pressure
Study 17587713 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15756035 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 7640431 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 7640431 — Safety Biomarker (SAF): Interleukin 1
Study 7640431 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 7640431 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31054159 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 31054159 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 25948166 — Surrogate Endpoint (SUR): Forced vital capacity
Study 23541971 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 20519697 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 20519697 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 11590500 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 11590500 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 8147960 — Surrogate Endpoint (SUR): Serum creatinine
Study 30883331 — Predictive Biomarker (PRD): PPT1 mRNA
Genes: PPT1; CLN1; PPT
Study 26707134 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 29962254 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 29962254 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23518604 — Surrogate Endpoint (SUR): Blood pressure
Study 3139285 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 3139285 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 3139285 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 26910333 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 26910333 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 16611715 — Surrogate Endpoint (SUR): Serum creatinine
Study 14606990 — Predictive Biomarker (PRD): TSTD1 mRNA
Genes: TSTD1; KAT
Study 27447428 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 20561625 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30092952 — Surrogate Endpoint (SUR): Serum creatinine
Study 26896263 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 18618943 — Surrogate Endpoint (SUR): Blood pressure
Study 31817080 — Surrogate Endpoint (SUR): Blood pressure
Study 27448761 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 27448761 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 9848512 — Predictive Biomarker (PRD): Proliferation marker protein Ki-67
Genes: MKI67
Study 31056306 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 31056306 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 21316752 — Surrogate Endpoint (SUR): Blood pressure
Study 17557211 — Predictive Biomarker (PRD): SRM mRNA
Genes: SRM; SPS1; SRML1
Study 26460661 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20130401 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study 9749162 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 2459514 — Surrogate Endpoint (SUR): Blood pressure
Study 12392830 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 18586578 — Surrogate Endpoint (SUR): Bone mineral density
Study 19436039 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study 12848875 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12848875 — Surrogate Endpoint (SUR): Blood pressure
Study 22180633 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 31369706 — Predictive Biomarker (PRD): FN1 mRNA
Genes: FN1; FN
Study 31369706 — Predictive Biomarker (PRD): A2M mRNA
Genes: A2M; CPAMD5; FWP007
Study 31369706 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 28066708 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 24423149 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 24423149 — Surrogate Endpoint (SUR): Blood pressure
Study 10098460 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 11812697 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 31017569 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 19516185 — Surrogate Endpoint (SUR): Blood pressure
Study 9724682 — Surrogate Endpoint (SUR): Bone mineral density
Study 25035126 — Predictive Biomarker (PRD): SP2 mRNA
Genes: SP2; KIAA0048
Study 15045502 — Surrogate Endpoint (SUR): Blood pressure
Study 29373148 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 29305130 — Predictive Biomarker (PRD): OGG1 mRNA
Genes: OGG1; MMH; MUTM; OGH1
Study 26599222 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 26599222 — Surrogate Endpoint (SUR): Blood pressure
Study 20410835 — Surrogate Endpoint (SUR): Blood pressure
Study 29685792 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29685792 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 17685675 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 20537177 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 18566295 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 27227933 — Surrogate Endpoint (SUR): Serum creatinine
Study 24703574 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 10490792 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 26094050 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study 2108196 — Predictive Biomarker (PRD): HCG22 mRNA
Genes: HCG22; G2; PBMUCL2
Study 26519114 — Surrogate Endpoint (SUR): Blood pressure
Study 26519114 — Surrogate Endpoint (SUR): Serum potassium
Study 30556913 — Predictive Biomarker (PRD): CFP mRNA
Genes: CFP; PFC
Study 21292898 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 9296473 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21122057 — Surrogate Endpoint (SUR): Blood pressure
Study 11012557 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 11012557 — Predictive Biomarker (PRD): DDR1 mRNA
Genes: DDR1; CAK; EDDR1; NEP; NTRK4; PTK3A; RTK6; TRKE
Study 11012557 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 11012557 — Surrogate Endpoint (SUR): Blood pressure
Study 31645472 — Surrogate Endpoint (SUR): Blood pressure
Study 28193176 — Surrogate Endpoint (SUR): Blood pressure
Study 22395672 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19775480 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 17213294 — Predictive Biomarker (PRD): UBXN11 mRNA
Genes: UBXN11; SOC; UBXD5; PP2243
Study 31729520 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19815243 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19815243 — Surrogate Endpoint (SUR): Blood pressure
Study 9917435 — Predictive Biomarker (PRD): ZMYM2 mRNA
Genes: ZMYM2; FIM; RAMP; ZNF198
Study 31095461 — Surrogate Endpoint (SUR): Blood pressure
Study 26051163 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study 11887037 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 9170575 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 9170575 — Predictive Biomarker (PRD): GPT mRNA
Genes: GPT; AAT1; GPT1
Study 21194608 — Surrogate Endpoint (SUR): Blood pressure
Study 23622850 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study 16671428 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 27267710 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22678090 — Surrogate Endpoint (SUR): Blood pressure
Study 12107216 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31768803 — Surrogate Endpoint (SUR): Blood pressure
Study 31768803 — Surrogate Endpoint (SUR): Serum calcium
Study 31768803 — Surrogate Endpoint (SUR): Serum potassium
Study 2860990 — Surrogate Endpoint (SUR): Blood pressure
Study 21178182 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study 17705242 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 31764984 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31764984 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 19533481 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 8294084 — Safety Biomarker (SAF): Protein AMBP
Genes: AMBP; HCP; ITIL
Study 8294084 — Surrogate Endpoint (SUR): Blood pressure
Study 31732448 — Predictive Biomarker (PRD): SST mRNA
Genes: SST
Study 28974102 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 28028373 — Surrogate Endpoint (SUR): Blood pressure
Study 12190100 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 11012554 — Surrogate Endpoint (SUR): Serum creatinine
Study 25933490 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25933490 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 371034 — Predictive Biomarker (PRD): OPN1SW mRNA
Genes: OPN1SW; BCP
Study 29576595 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 29576595 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 10890777 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 1835398 — Surrogate Endpoint (SUR): Serum calcium
Study 6119766 — Pharmacodynamic Biomarker (PDY): Salivary secretion
Study 30261783 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30261783 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 28973362 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 28973362 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 21571547 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study 18844760 — Surrogate Endpoint (SUR): Blood pressure
Study 13680163 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 6419958 — Surrogate Endpoint (SUR): Blood pressure
Study 21266513 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29304325 — Safety Biomarker (SAF): Hyaluronic acid
Study 28070894 — Predictive Biomarker (PRD): TPI1 mRNA
Genes: TPI1; TPI
Study 20981000 — Predictive Biomarker (PRD): HRH3 mRNA
Genes: HRH3; GPCR97
Study 15845499 — Surrogate Endpoint (SUR): Serum bactericidal antibody
Study 11918735 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2